Cargando…
Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response
PANoptosis, an interplay between pyroptosis, apoptosis, and necroptosis, is deeply involved in cancer development and immunity. However, the influence of PANoptosis in hepatocellular carcinoma (HCC) remains to be further investigated. The differentially expressed PANoptosis-related genes (PANRGs) wa...
Autores principales: | Wei, Yongguang, Lan, Chenlu, Yang, Chengkun, Liao, Xiwen, Zhou, Xin, Huang, Xinlei, Xie, Haixiang, Zhu, Guangzhi, Peng, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477271/ https://www.ncbi.nlm.nih.gov/pubmed/37666920 http://dx.doi.org/10.1038/s41598-023-41670-9 |
Ejemplares similares
-
PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
por: Lan, Chenlu, et al.
Publicado: (2023) -
RAD51AP1 as an Immune-Related Prognostic Biomarker and Therapeutic Response Predictor in Hepatocellular Carcinoma
por: Wei, Yongguang, et al.
Publicado: (2023) -
SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma
por: Nong, Jusen, et al.
Publicado: (2023) -
PANoptosis-related prognostic signature predicts overall survival of cutaneous melanoma and provides insights into immune infiltration landscape
por: Wang, Wei, et al.
Publicado: (2023) -
Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma
por: Xiong, Xiaofeng, et al.
Publicado: (2023)